Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models

International Journal of Oncology

Volumn 27, Issue 4, 2005, Pages 901-906

  Himeno, Yoshihisa ^a   Etoh, Tsuyoshi ^a   Matsumoto, Toshifumi ^a   Ohta, Masayuki ^a   Nishizono, Akira ^a   Kitano, Seigo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Immunocompetent model; Liver metastasis; Pancreatic cancer; Reovirus

Indexed keywords

ONCOLYTIC VIRUS; RAS PROTEIN;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL STRAIN 3T3; DISEASE MODEL; GENE THERAPY; GENETICS; HAMSTER; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TUMOR; METABOLISM; METASTASIS; METHODOLOGY; MOUSE; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; SYRIAN HAMSTER; TIME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CRICETINAE; DISEASE MODELS, ANIMAL; GENE THERAPY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MESOCRICETUS; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; ONCOLYTIC VIRUSES; PANCREATIC NEOPLASMS; RAS PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 33644824192     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.4.901     Document Type: Article

References (29)

1. Niederhuber JE, Brennan MF and Menck HR: The National Cancer Data Base report on pancreatic cancer. Cancer 76: 1671-1677, 1995.
2. Birk D, Schoenberg MH, Gansauge F, Formentini A, Fortnagel G and Beger HG: Carcinoma of the head of the pancreas arising from the uncinate process. Br J Surg 85: 498-501, 1998.
3. Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RE and Evans RG: Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66: 56-61, 1990.
4. Westerdahl J, Andren-Sandberg A and Ihse I: Recurrence of exocrine pancreatic cancer - local or hepatic? Hepatogastroenterology 40: 384-387, 1993.
5. Sperti C, Pasquali C, Piccoli A and Pedrazzoli S: Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83:625-631, 1996.
6. Ikeda M, Okada S, Tokuuye K, Ueno H and Okusaka T: Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy. Cancer 91: 490-495, 2001.
7. Ueno H, Okada S, Okusaka T and Ikeda M: Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 59: 296-301, 2000.
8. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A and McCormick F: An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274: 373-376, 1996.
9. Mineta T, Rabkin SD, Yazaki T, Hunter WD and Martuza RL: Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med 1:938-943, 1995.
10. Tyler KL and Fields BN: Reoviruses. In: Fields Virology. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven, Philadelphia, ppl597-1632, 1996.
11. Strong JE, Coffey MC, Tang D, Sabinin P and Lee PW: The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 17: 3351-3362, 1998.
12. Wilcox ME, Yang W, Senger D, Rewcastle NB, Morris DG, Brasher PM, Shi ZQ, Johnston RN, Nishikawa S, Lee PW and Forsyth PA: Reovirus as an oncolytic agent against experimental human malignant gliomas. J Natl Cancer Inst 93: 903-912, 2001.
13. Hirasawa K, Nishikawa SG, Norman KL, Alain T, Kossakowska A and Lee PW: Oncolytic reovirus against ovarian and colon cancer. Cancer Res 62: 1696-1701,2002.
14. Norman KL, Coffey MC, Hirasawa K, Demetrick DJ, Nishikawa SG, Di Francesco LM, Strong JE and Lee PW: Reovirus oncolysis of human breast cancer. Hum Gene Ther 13: 641-652,2002.
15. Alain T, Hirasawa K, Pon KJ, Nishikawa SG, Urbanski SJ, Auer Y, Luider J, Martin A, Johnston RN, Janowska- Wieczorek A, Lee PW and Kossakowska AE: Reovirus therapy of lymphoid malignancies. Blood 100: 4146-4153, 2002.
16. Etoh T, Himeno Y, Matsumoto T, Aramaki M, Kawano K, Nishizono A and Kitano S: Oncolytic viral therapy for human pancreatic cancercells by reovirus. Clin Cancer Res 9: 1218-1223, 2003.
17. Lee PW, Hayes EC and Joklik WK: Protein sigma 1 is the reovirus cell attachment protein. Virology 108: 156-163, 1981.
18. Mulvihill S, Warren R, Venook A, Adler A, Randlev B, Heise C and Kirn D: Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther 8: 308-315, 2001.
19. Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, Kim DH and Freeman SM: A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 9: 555-561, 2003.
20. Hirasawa K, Nishikawa SG, Norman KL, Coffey MC, Thompson BG, Yoon CS, Waisman DM and Lee PW: Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res 63: 348-353, 2003.
21. Reid T, Galanis E, Abbruzzese J, Sze D, Andrews J, Romel L, Hatfield M, Rubin J and Kirn D: Intra-arterial administration of a replication-selective adenovirus (dl I520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Ther 8: 1618-1626,2001.
22. Reid T, Galanis E, Abbruzzese J, Sze D, Wein LM, Andrews J, Randlev B, Heise C, Uprichard M, Hatfield M, Rome L, Rubin J and Kirn D: Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl 1520): phase II viral, immunologic, and clinical endpoints. Cancer Res 62: 6070-6079, 2002.
23. Herrlinger U, Kramm CM, Aboody-Guterman KS, Silver JS, Ikeda K, Johnston KM, Pechan PA, Barth RF, Finkelstein D, Chiocca EA, Louis DN and Breakefield XO: Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector. Gene Ther 5: 809-819, 1998.
24. Chahlavi A, Rabkin S, Todo T, Sundaresan P and Martuza R: Effect of prior exposure to herpes simplex virus 1 on viral vectormediated tumor therapy in immunocompetent mice. Gene Ther 6: 1751-1758, 1999.
25. Ishikawa O, Ohigashi H, Sasaki Y, Furukawa H, Kabuto T, Kameyama M, Nakamori S, Hiratsuka M and Imaoka S: Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 168: 361-364, 1994.
26. Korst RJ, Ailawadi M, Lee JM, Lee S, Yamada R, Mahtabifard A and Crystal RG: Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene. Hum Gene Ther 12: 1639-1649, 2001.
27. Nakano K, Todo T, Chijiiwa K and Tanaka M: Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters. Mol Ther 3: 431-437, 2001.
28. Yang WQ, Lun X, Palmer CA, Wilcox ME, Muzik H, Shi ZQ, Dyck R, Coffey M, Thompson B, Hamilton M, Nishikawa SG, Brasher PM, Fonseca K, George D, Rewcastle NB, Johnston RN, Stewart D, Lee PW, Senger DL and Forsyth PA: Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and non-human primates. Clin Cancer Res 10: 8561-8576,2004.
29. Demers GW, Johnson DE, Tsai V, Wen SF, Quijano E, Machemer T, Philopena J, Ramachandra M, Howe JA, Shabram P, Ralston R and Engler H: Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy. Cancer Res 63: 4003-4008, 2003.